Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tadenan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
OBJECTIVES Pretreatment with oral tadenan (TAD) has been shown to possess a protective effect on bladder dysfunction-induced… Expand
Is this relevant?
2000
2000
OBJECTIVES To evaluate the effect of Tadenan (TAD; Pygeum africanum extract) pretreatment on the micturition characteristics of… Expand
Is this relevant?
2000
2000
PURPOSE Tadenan is a plant extract from Pygeum africanum used in the treatment of benign prostatic hyperplasia, to protect the… Expand
Is this relevant?
1998
1998
Pygeum africanum extract is available as Tadenan in many countries, including those in central and eastern Europe, for the… Expand
Is this relevant?
1997
1997
Bladder dysfunction secondary to benign prostatic hyperplasia (BPH) is a major affliction associated with ageing. As the disease… Expand
Is this relevant?
1997
1997
Tadenan (Debat Laboratories, France) is a plant extract used in Europe for the treatment of micturition disorders associated with… Expand
Is this relevant?
1996
1996
PURPOSE Tadenan is a pharmaceutical agent used in the treatment of BPH. Prior studies demonstrated that pretreatment of rabbits… Expand
Is this relevant?
1996
1996
PURPOSE Tadenan (DEBAT, Paris, France) is a pharmaceutical agent used in the treatment of benign prostatic hyperplasia (BPH). The… Expand
Is this relevant?
1993
1993
Human prostate was used as a source of 5 alpha reductase. Compounds were incubated with an enzyme preparation and [3H… Expand
Is this relevant?
Highly Cited
1984
Highly Cited
1984
The benign hyperplasia of the prostate is a manifestation of aging, involving the accumulation, within the gland, of… Expand
Is this relevant?